FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2119831745> ?p ?o ?g. }

• W2119831745 endingPage "285" @default.
• W2119831745 startingPage "278" @default.
• W2119831745 abstract "<h3>OBJECTIVE</h3> To examine whether successful coronary reperfusion after thrombolytic treatment in patients with confirmed acute myocardial infarction can be diagnosed from the plasma marker fatty acid binding protein (FABP), for either acute clinical decision making or retrospective purposes. <h3>DESIGN</h3> Retrospective substudy of the GUSTO trial. <h3>SETTING</h3> 10 hospitals in four European countries. <h3>PATIENTS</h3> 115 patients were treated with thrombolytic agents within six hours after the onset of acute myocardial infarction. Patency of the infarct related artery was determined by angiography within 120 minutes of the start of thrombolysis. <h3>MAIN OUTCOME MEASURES</h3> First hour rate of increase in plasma FABP concentration after thrombolytic treatment, compared with increase in plasma myoglobin concentration and creatine kinase isoenzyme MB (CK-MB) activity. Infarct size was estimated from the cumulative release of the enzyme α hydroxybutyrate dehydrogenase in plasma during 72 hours, or from the sum of ST segment elevations on admission. Logistic regression analyses were performed to construct predictive models for patency. <h3>RESULTS</h3> Complete reperfusion (TIMI 3) occurred in 50 patients, partial reperfusion (TIMI 2) in 36, and no reperfusion (TIMI 0+1) in 29. Receiver operating characteristic (ROC) curve analyses showed that the best performance of FABP was obtained when TIMI scores 2 and 3 were grouped and compared with TIMI score 0+1. The performance of FABP as a reperfusion marker was improved by combining it with α hydroxybutyrate dehydrogenase infarct size, but not with an early surrogate of infarct size (ST segment elevation on admission). In combination with infarct size FABP performed as well as myoglobin (areas under the ROC curve 0.868 and 0.857, respectively) and better than CK-MB (area = 0.796). At optimum cut off levels, positive predictive values were 97% for FABP, 95% for myoglobin, and 89% for CK-MB (without infarct size, 87%, 88%, and 87%, respectively), and negative predictive values were 55%, 52%, and 50%, respectively (without infarct size, 44%, 42%, and 34%). <h3>CONCLUSIONS</h3> FABP and myoglobin perform equally well as reperfusion markers, and successful reperfusion can be assessed, with positive predictive values of 87% and 88%, or even 97% and 95% when infarct size is also taken into account. However, identification of non-reperfused patients remains a problem, as negative predictive values will generally remain below 70%." @default.
• W2119831745 created "2016-06-24" @default.
• W2119831745 creator A5000830448 @default.
• W2119831745 creator A5015610233 @default.
• W2119831745 creator A5072123276 @default.
• W2119831745 creator A5079557739 @default.
• W2119831745 creator A5080047007 @default.
• W2119831745 date "2001-03-01" @default.
• W2119831745 modified "2023-10-10" @default.
• W2119831745 title "Assessment of coronary reperfusion in patients with myocardial infarction using fatty acid binding protein concentrations in plasma" @default.
• W2119831745 cites W1970481575 @default.
• W2119831745 cites W1975630916 @default.
• W2119831745 cites W1976318744 @default.
• W2119831745 cites W1978158736 @default.
• W2119831745 cites W1981793521 @default.
• W2119831745 cites W1988226103 @default.
• W2119831745 cites W1988768888 @default.
• W2119831745 cites W1994387347 @default.
• W2119831745 cites W1995223316 @default.
• W2119831745 cites W2002321608 @default.
• W2119831745 cites W2013598574 @default.
• W2119831745 cites W2026091186 @default.
• W2119831745 cites W2046101623 @default.
• W2119831745 cites W2046145599 @default.
• W2119831745 cites W2054648577 @default.
• W2119831745 cites W2054979859 @default.
• W2119831745 cites W2072395415 @default.
• W2119831745 cites W2090131529 @default.
• W2119831745 cites W2100372252 @default.
• W2119831745 cites W2102150307 @default.
• W2119831745 cites W2112100612 @default.
• W2119831745 cites W2112911632 @default.
• W2119831745 cites W2116157424 @default.
• W2119831745 cites W2160187401 @default.
• W2119831745 cites W2168393286 @default.
• W2119831745 cites W2331858011 @default.
• W2119831745 cites W2415797987 @default.
• W2119831745 doi "https://doi.org/10.1136/heart.85.3.278" @default.
• W2119831745 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1729633" @default.
• W2119831745 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11179265" @default.
• W2119831745 hasPublicationYear "2001" @default.
• W2119831745 type Work @default.
• W2119831745 sameAs 2119831745 @default.
• W2119831745 citedByCount "26" @default.
• W2119831745 countsByYear W21198317452012 @default.
• W2119831745 countsByYear W21198317452021 @default.
• W2119831745 crossrefType "journal-article" @default.
• W2119831745 hasAuthorship W2119831745A5000830448 @default.
• W2119831745 hasAuthorship W2119831745A5015610233 @default.
• W2119831745 hasAuthorship W2119831745A5072123276 @default.
• W2119831745 hasAuthorship W2119831745A5079557739 @default.
• W2119831745 hasAuthorship W2119831745A5080047007 @default.
• W2119831745 hasBestOaLocation W21198317451 @default.
• W2119831745 hasConcept C104317684 @default.
• W2119831745 hasConcept C126322002 @default.
• W2119831745 hasConcept C164705383 @default.
• W2119831745 hasConcept C181199279 @default.
• W2119831745 hasConcept C185592680 @default.
• W2119831745 hasConcept C2776834966 @default.
• W2119831745 hasConcept C2777318727 @default.
• W2119831745 hasConcept C2777995511 @default.
• W2119831745 hasConcept C2779280647 @default.
• W2119831745 hasConcept C2779581417 @default.
• W2119831745 hasConcept C36880943 @default.
• W2119831745 hasConcept C500558357 @default.
• W2119831745 hasConcept C55493867 @default.
• W2119831745 hasConcept C71924100 @default.
• W2119831745 hasConceptScore W2119831745C104317684 @default.
• W2119831745 hasConceptScore W2119831745C126322002 @default.
• W2119831745 hasConceptScore W2119831745C164705383 @default.
• W2119831745 hasConceptScore W2119831745C181199279 @default.
• W2119831745 hasConceptScore W2119831745C185592680 @default.
• W2119831745 hasConceptScore W2119831745C2776834966 @default.
• W2119831745 hasConceptScore W2119831745C2777318727 @default.
• W2119831745 hasConceptScore W2119831745C2777995511 @default.
• W2119831745 hasConceptScore W2119831745C2779280647 @default.
• W2119831745 hasConceptScore W2119831745C2779581417 @default.
• W2119831745 hasConceptScore W2119831745C36880943 @default.
• W2119831745 hasConceptScore W2119831745C500558357 @default.
• W2119831745 hasConceptScore W2119831745C55493867 @default.
• W2119831745 hasConceptScore W2119831745C71924100 @default.
• W2119831745 hasIssue "3" @default.
• W2119831745 hasLocation W21198317451 @default.
• W2119831745 hasLocation W21198317452 @default.
• W2119831745 hasLocation W21198317453 @default.
• W2119831745 hasLocation W21198317454 @default.
• W2119831745 hasLocation W21198317455 @default.
• W2119831745 hasLocation W21198317456 @default.
• W2119831745 hasLocation W21198317457 @default.
• W2119831745 hasOpenAccess W2119831745 @default.
• W2119831745 hasPrimaryLocation W21198317451 @default.
• W2119831745 hasRelatedWork W130993255 @default.
• W2119831745 hasRelatedWork W1984774611 @default.
• W2119831745 hasRelatedWork W2009440191 @default.
• W2119831745 hasRelatedWork W2083860177 @default.
• W2119831745 hasRelatedWork W2088249991 @default.
• W2119831745 hasRelatedWork W2090944577 @default.
• W2119831745 hasRelatedWork W2094308415 @default.

• next